| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | NELL1 EYS SULF2 OIT3 NRXN1 SULF1 SLIT3 LRP4 ADGRE5 LTBP2 ADAMTS13 ITGB1 LDLR PCDH18 FBN3 NOTCH1 | 2.57e-08 | 749 | 78 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | fibronectin binding | 3.62e-07 | 38 | 78 | 5 | GO:0001968 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 9.88e-06 | 268 | 78 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | serpin family protein binding | 1.51e-05 | 2 | 78 | 2 | GO:0097655 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine-6-sulfatase activity | 4.51e-05 | 3 | 78 | 2 | GO:0008449 | |
| GeneOntologyMolecularFunction | cysteine-type carboxypeptidase activity | 8.99e-05 | 4 | 78 | 2 | GO:0016807 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.41e-05 | 188 | 78 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | kininogen binding | 1.49e-04 | 5 | 78 | 2 | GO:0030984 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity involved in apoptotic process | 1.95e-04 | 29 | 78 | 3 | GO:0008656 | |
| GeneOntologyMolecularFunction | peptidase activator activity involved in apoptotic process | 2.62e-04 | 32 | 78 | 3 | GO:0016505 | |
| GeneOntologyMolecularFunction | collagen binding | 2.85e-04 | 81 | 78 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 3.59e-04 | 86 | 78 | 4 | GO:0004197 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.35e-04 | 599 | 78 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | integrin binding | 6.15e-04 | 175 | 78 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | cysteine-type exopeptidase activity | 6.64e-04 | 10 | 78 | 2 | GO:0070004 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 9.28e-04 | 49 | 78 | 3 | GO:0004180 | |
| GeneOntologyMolecularFunction | heparin binding | 9.33e-04 | 192 | 78 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.04e-03 | 51 | 78 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 1.23e-03 | 54 | 78 | 3 | GO:0043028 | |
| GeneOntologyMolecularFunction | arylsulfatase activity | 1.33e-03 | 14 | 78 | 2 | GO:0004065 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.33e-03 | 14 | 78 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.65e-03 | 323 | 78 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 1.97e-03 | 17 | 78 | 2 | GO:0008484 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT31 KRT33A KRT33B KRT34 COL28A1 LAMA3 LAMB1 LTBP2 SSPOP FBN3 | 2.39e-03 | 891 | 78 | 10 | GO:0005198 |
| GeneOntologyMolecularFunction | peptidase activator activity | 2.60e-03 | 70 | 78 | 3 | GO:0016504 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 3.34e-03 | 257 | 78 | 5 | GO:0061134 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 3.61e-03 | 23 | 78 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | virus receptor activity | 4.50e-03 | 85 | 78 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.53e-03 | 171 | 78 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.61e-03 | 26 | 78 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 4.61e-03 | 26 | 78 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 4.65e-03 | 86 | 78 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | Notch binding | 4.96e-03 | 27 | 78 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 6.71e-03 | 430 | 78 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 6.79e-03 | 192 | 78 | 4 | GO:0008234 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | SULF2 SULF1 COL28A1 ADAMTS16 LAMB1 ADAMTS13 ITGB1 CTSK CTSV NOTCH1 | 1.36e-06 | 377 | 77 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | SULF2 SULF1 COL28A1 ADAMTS16 LAMB1 ADAMTS13 ITGB1 CTSK CTSV NOTCH1 | 1.40e-06 | 378 | 77 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | SULF2 SULF1 COL28A1 ADAMTS16 LAMB1 ADAMTS13 ITGB1 CTSK CTSV NOTCH1 | 1.43e-06 | 379 | 77 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | esophagus smooth muscle contraction | 1.38e-05 | 2 | 77 | 2 | GO:0014846 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast growth factor receptor signaling pathway | 2.18e-05 | 44 | 77 | 4 | GO:0040036 | |
| GeneOntologyBiologicalProcess | glial cell-derived neurotrophic factor receptor signaling pathway | 2.20e-05 | 15 | 77 | 3 | GO:0035860 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 2.86e-05 | 236 | 77 | 7 | GO:0061138 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 4.58e-05 | 53 | 77 | 4 | GO:0030574 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.04e-05 | 258 | 77 | 7 | GO:0001763 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SLC6A4 SULF2 CSF3R TENM3 SULF1 SLIT3 ADAMTS16 LAMA3 LRP4 LAMB1 PLXND1 CSMD1 CTSL CTSV NOTCH1 | 6.02e-05 | 1269 | 77 | 15 | GO:0009887 |
| GeneOntologyBiologicalProcess | hair cycle phase | 8.40e-05 | 23 | 77 | 3 | GO:0044851 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 9.76e-05 | 198 | 77 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | thyroid hormone generation | 1.08e-04 | 25 | 77 | 3 | GO:0006590 | |
| GeneOntologyBiologicalProcess | hair follicle maturation | 1.70e-04 | 29 | 77 | 3 | GO:0048820 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.78e-04 | 75 | 77 | 4 | GO:0045109 | |
| GeneOntologyBiologicalProcess | regulation of Rab protein signal transduction | 2.04e-04 | 6 | 77 | 2 | GO:0032483 | |
| GeneOntologyBiologicalProcess | conditioned place preference | 2.04e-04 | 6 | 77 | 2 | GO:1990708 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 2.32e-04 | 148 | 77 | 5 | GO:0032963 | |
| GeneOntologyBiologicalProcess | renal system process | 2.39e-04 | 149 | 77 | 5 | GO:0003014 | |
| GeneOntologyBiologicalProcess | molting cycle | 2.47e-04 | 150 | 77 | 5 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 2.47e-04 | 150 | 77 | 5 | GO:0042633 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | NRXN1 SULF1 ADGRB2 ADAMTS16 ADGRF5 MINAR1 PLXND1 CSMD1 ITGB1 CTSL CTSV LDLR NOTCH1 | 2.49e-04 | 1125 | 77 | 13 | GO:0035239 |
| GeneOntologyBiologicalProcess | glomerular filtration | 2.52e-04 | 33 | 77 | 3 | GO:0003094 | |
| GeneOntologyBiologicalProcess | thyroid hormone metabolic process | 2.75e-04 | 34 | 77 | 3 | GO:0042403 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SULF2 FSTL3 NRXN1 SULF1 VEPH1 LTBP2 CORO1B ITGB1 CTSK GFRA1 NOTCH1 | 3.04e-04 | 850 | 77 | 11 | GO:0071363 |
| GeneOntologyBiologicalProcess | renal filtration | 3.27e-04 | 36 | 77 | 3 | GO:0097205 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 3.80e-04 | 8 | 77 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | response to growth factor | SULF2 FSTL3 NRXN1 SULF1 VEPH1 LTBP2 CORO1B ITGB1 CTSK GFRA1 NOTCH1 | 4.19e-04 | 883 | 77 | 11 | GO:0070848 |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 4.27e-04 | 169 | 77 | 5 | GO:0046718 | |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 4.47e-04 | 40 | 77 | 3 | GO:0031069 | |
| GeneOntologyBiologicalProcess | kidney development | 4.77e-04 | 372 | 77 | 7 | GO:0001822 | |
| GeneOntologyBiologicalProcess | catagen | 4.87e-04 | 9 | 77 | 2 | GO:0042637 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway | 4.97e-04 | 98 | 77 | 4 | GO:0008543 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 5.14e-04 | 176 | 77 | 5 | GO:0044409 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 5.17e-04 | 99 | 77 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 5.37e-04 | 100 | 77 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 5.41e-04 | 178 | 77 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | renal system development | 5.94e-04 | 386 | 77 | 7 | GO:0072001 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 6.07e-04 | 10 | 77 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | elastin catabolic process | 6.07e-04 | 10 | 77 | 2 | GO:0060309 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 6.07e-04 | 10 | 77 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 6.77e-04 | 46 | 77 | 3 | GO:0048730 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast growth factor receptor signaling pathway | 7.40e-04 | 11 | 77 | 2 | GO:0045743 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 7.40e-04 | 11 | 77 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.72e-04 | 412 | 77 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell myoblast differentiation | 8.86e-04 | 12 | 77 | 2 | GO:0060379 | |
| GeneOntologyBiologicalProcess | biological phase | 1.02e-03 | 53 | 77 | 3 | GO:0044848 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.04e-03 | 13 | 77 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | hair follicle development | 1.16e-03 | 123 | 77 | 4 | GO:0001942 | |
| GeneOntologyBiologicalProcess | cellular response to fibroblast growth factor stimulus | 1.20e-03 | 124 | 77 | 4 | GO:0044344 | |
| GeneOntologyBiologicalProcess | elastin metabolic process | 1.22e-03 | 14 | 77 | 2 | GO:0051541 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.22e-03 | 566 | 77 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.27e-03 | 126 | 77 | 4 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.27e-03 | 126 | 77 | 4 | GO:0022405 | |
| GeneOntologyCellularComponent | cell surface | HAVCR1 SULF2 CSF3R NRXN1 SULF1 CD53 LRP4 ADGRF5 ADGRE5 ADAMTS13 CAPN5 CLEC10A ELSPBP1 ITGB1 CTSK CTSL CTSV LDLR GFRA1 NOTCH1 | 2.22e-09 | 1111 | 77 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | extracellular matrix | EYS SULF1 COL28A1 ADAMTS16 LAMA3 LAMB1 LTBP2 ADAMTS13 ITGB1 SSPOP CTSL CTSV FBN3 | 7.37e-07 | 656 | 77 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | EYS SULF1 COL28A1 ADAMTS16 LAMA3 LAMB1 LTBP2 ADAMTS13 ITGB1 SSPOP CTSL CTSV FBN3 | 7.63e-07 | 658 | 77 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.41e-05 | 530 | 77 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | apical part of cell | 6.13e-05 | 592 | 77 | 10 | GO:0045177 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.21e-04 | 519 | 77 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | endolysosome lumen | 1.33e-04 | 5 | 77 | 2 | GO:0036021 | |
| GeneOntologyCellularComponent | endolysosome | 1.82e-04 | 30 | 77 | 3 | GO:0036019 | |
| GeneOntologyCellularComponent | laminin complex | 5.91e-04 | 10 | 77 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | hemidesmosome | 7.21e-04 | 11 | 77 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | basement membrane | 1.08e-03 | 122 | 77 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.35e-03 | 59 | 77 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.35e-03 | 583 | 77 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | side of membrane | 1.36e-03 | 875 | 77 | 10 | GO:0098552 | |
| MousePheno | amyloidosis | 1.88e-05 | 35 | 64 | 4 | MP:0000604 | |
| MousePheno | abnormal amyloid deposition | 1.88e-05 | 35 | 64 | 4 | MP:0021152 | |
| MousePheno | periodontal ligament necrosis | 2.06e-05 | 2 | 64 | 2 | MP:0030515 | |
| MousePheno | abnormal lymph node medullary sinus morphology | 2.06e-05 | 2 | 64 | 2 | MP:0011222 | |
| MousePheno | dilated lymph node medullary sinus | 2.06e-05 | 2 | 64 | 2 | MP:0011223 | |
| MousePheno | greasy coat | 5.95e-05 | 17 | 64 | 3 | MP:0003849 | |
| MousePheno | absent kidney | 9.89e-05 | 53 | 64 | 4 | MP:0000520 | |
| MousePheno | folliculitis | 2.05e-04 | 5 | 64 | 2 | MP:0000376 | |
| MousePheno | dental pulp necrosis | 2.05e-04 | 5 | 64 | 2 | MP:0013251 | |
| MousePheno | hair follicle outer root sheath hyperplasia | 2.05e-04 | 5 | 64 | 2 | MP:0010688 | |
| MousePheno | enlarged thymus cortex | 2.05e-04 | 5 | 64 | 2 | MP:0013593 | |
| MousePheno | abnormal heart valve physiology | 3.40e-04 | 30 | 64 | 3 | MP:0011926 | |
| MousePheno | mitral valve regurgitation | 4.27e-04 | 7 | 64 | 2 | MP:0006045 | |
| MousePheno | increased macrophage derived foam cell number | 4.27e-04 | 7 | 64 | 2 | MP:0004778 | |
| MousePheno | abnormal R wave | 4.27e-04 | 7 | 64 | 2 | MP:0011919 | |
| MousePheno | foam cell reticulosis | 4.27e-04 | 7 | 64 | 2 | MP:0009841 | |
| MousePheno | abnormal periodontium morphology | 4.95e-04 | 34 | 64 | 3 | MP:0030131 | |
| MousePheno | dilated piliary canal | 5.68e-04 | 8 | 64 | 2 | MP:0030571 | |
| MousePheno | abnormal macrophage derived foam cell morphology | 5.68e-04 | 8 | 64 | 2 | MP:0008243 | |
| MousePheno | sparse vibrissae | 5.68e-04 | 8 | 64 | 2 | MP:0001283 | |
| MousePheno | abnormal myeloid leukocyte morphology | HAVCR1 CSF3R NRXN1 KRT33A KRT33B ADAMTS16 LAMA3 ADGRF5 ADGRE5 CLEC10A CTSK CTSL CTSV LDLR PLAC8 | 5.86e-04 | 1292 | 64 | 15 | MP:0008250 |
| MousePheno | abnormal epidermis stratum basale morphology | 6.36e-04 | 37 | 64 | 3 | MP:0001231 | |
| MousePheno | abnormal T wave | 7.28e-04 | 9 | 64 | 2 | MP:0010505 | |
| MousePheno | abnormal ureteric bud invasion | 7.28e-04 | 9 | 64 | 2 | MP:0010983 | |
| MousePheno | increased heart left atrium size | 7.28e-04 | 9 | 64 | 2 | MP:0008726 | |
| MousePheno | hypergranulosis | 7.28e-04 | 9 | 64 | 2 | MP:0009600 | |
| MousePheno | focal dorsal hair loss | 7.28e-04 | 9 | 64 | 2 | MP:0010202 | |
| MousePheno | abnormal hair cycle catagen phase | 7.28e-04 | 9 | 64 | 2 | MP:0008859 | |
| Domain | EGF | NELL1 EYS OIT3 NRXN1 TENM3 ATRNL1 SLIT3 LAMA3 LRP4 LAMB1 ADGRE5 LTBP2 LDLR FBN3 NOTCH1 GPR179 | 1.31e-15 | 235 | 76 | 16 | SM00181 |
| Domain | EGF_1 | NELL1 EYS OIT3 NRXN1 TENM3 ATRNL1 SLIT3 LAMA3 LRP4 LAMB1 LTBP2 ITGB1 SSPOP LDLR FBN3 NOTCH1 | 4.75e-15 | 255 | 76 | 16 | PS00022 |
| Domain | EGF-like_dom | NELL1 EYS OIT3 NRXN1 TENM3 ATRNL1 SLIT3 LAMA3 LRP4 LAMB1 ADGRE5 LTBP2 LDLR FBN3 NOTCH1 | 6.75e-14 | 249 | 76 | 15 | IPR000742 |
| Domain | EGF_2 | NELL1 EYS OIT3 NRXN1 TENM3 ATRNL1 SLIT3 LAMA3 LRP4 LAMB1 LTBP2 SSPOP LDLR FBN3 NOTCH1 | 1.68e-13 | 265 | 76 | 15 | PS01186 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NELL1 EYS OIT3 NRXN1 SLIT3 LRP4 ADGRE5 LTBP2 LDLR FBN3 NOTCH1 | 4.87e-13 | 106 | 76 | 11 | IPR000152 |
| Domain | EGF_3 | NELL1 EYS OIT3 NRXN1 TENM3 ATRNL1 SLIT3 LRP4 ADGRE5 LTBP2 SSPOP LDLR FBN3 NOTCH1 | 5.82e-13 | 235 | 76 | 14 | PS50026 |
| Domain | Growth_fac_rcpt_ | NELL1 EYS SLIT3 LAMA3 LRP4 LAMB1 ADGRE5 LTBP2 LDLR FBN3 NOTCH1 GPR179 | 1.47e-12 | 156 | 76 | 12 | IPR009030 |
| Domain | EGF-like_CS | NELL1 EYS NRXN1 TENM3 ATRNL1 SLIT3 LAMA3 LRP4 LAMB1 LTBP2 ITGB1 LDLR FBN3 NOTCH1 | 2.43e-12 | 261 | 76 | 14 | IPR013032 |
| Domain | EGF_Ca-bd_CS | 6.39e-12 | 97 | 76 | 10 | IPR018097 | |
| Domain | EGF_CA | 7.86e-12 | 99 | 76 | 10 | PS01187 | |
| Domain | ASX_HYDROXYL | 8.71e-12 | 100 | 76 | 10 | PS00010 | |
| Domain | EGF_CA | 6.46e-11 | 122 | 76 | 10 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.60e-11 | 124 | 76 | 10 | IPR001881 | |
| Domain | EGF_CA | 5.79e-08 | 86 | 76 | 7 | PF07645 | |
| Domain | EGF_extracell | 1.56e-07 | 60 | 76 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.56e-07 | 60 | 76 | 6 | PF07974 | |
| Domain | Laminin_G_2 | 5.75e-07 | 40 | 76 | 5 | PF02210 | |
| Domain | EGF | 7.99e-07 | 126 | 76 | 7 | PF00008 | |
| Domain | LamG | 9.37e-07 | 44 | 76 | 5 | SM00282 | |
| Domain | Inhibitor_I29 | 2.24e-06 | 7 | 76 | 3 | PF08246 | |
| Domain | Prot_inhib_I29 | 2.24e-06 | 7 | 76 | 3 | IPR013201 | |
| Domain | Inhibitor_I29 | 2.24e-06 | 7 | 76 | 3 | SM00848 | |
| Domain | THIOL_PROTEASE_CYS | 3.54e-06 | 26 | 76 | 4 | PS00139 | |
| Domain | - | 3.57e-06 | 8 | 76 | 3 | 3.90.290.10 | |
| Domain | Laminin_G | 3.78e-06 | 58 | 76 | 5 | IPR001791 | |
| Domain | THIOL_PROTEASE_ASN | 4.14e-06 | 27 | 76 | 4 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 4.14e-06 | 27 | 76 | 4 | PS00639 | |
| Domain | Pept_cys_AS | 4.81e-06 | 28 | 76 | 4 | IPR000169 | |
| Domain | TB | 5.34e-06 | 9 | 76 | 3 | PS51364 | |
| Domain | TB_dom | 5.34e-06 | 9 | 76 | 3 | IPR017878 | |
| Domain | Pept_asp_AS | 7.61e-06 | 10 | 76 | 3 | IPR025661 | |
| Domain | Pept_his_AS | 1.04e-05 | 11 | 76 | 3 | IPR025660 | |
| Domain | Extracellular_sulfatase | 1.63e-05 | 2 | 76 | 2 | IPR014615 | |
| Domain | Extracellular_sulfatase_C | 1.63e-05 | 2 | 76 | 2 | IPR024609 | |
| Domain | DUF3740 | 1.63e-05 | 2 | 76 | 2 | PF12548 | |
| Domain | LAM_G_DOMAIN | 1.68e-05 | 38 | 76 | 4 | PS50025 | |
| Domain | Pept_C1 | 1.80e-05 | 13 | 76 | 3 | SM00645 | |
| Domain | Peptidase_C1A_C | 1.80e-05 | 13 | 76 | 3 | IPR000668 | |
| Domain | Peptidase_C1 | 1.80e-05 | 13 | 76 | 3 | PF00112 | |
| Domain | Peptidase_C1A | 1.80e-05 | 13 | 76 | 3 | IPR013128 | |
| Domain | Keratin_I | 3.04e-05 | 44 | 76 | 4 | IPR002957 | |
| Domain | - | 4.25e-05 | 95 | 76 | 5 | 2.60.120.200 | |
| Domain | CUB | 6.37e-05 | 53 | 76 | 4 | PS01180 | |
| Domain | CUB_dom | 8.49e-05 | 57 | 76 | 4 | IPR000859 | |
| Domain | Intermediate_filament_CS | 1.26e-04 | 63 | 76 | 4 | IPR018039 | |
| Domain | TSP_1 | 1.26e-04 | 63 | 76 | 4 | PF00090 | |
| Domain | TSP1 | 1.42e-04 | 65 | 76 | 4 | SM00209 | |
| Domain | TSP1_rpt | 1.42e-04 | 65 | 76 | 4 | IPR000884 | |
| Domain | TSP1 | 1.42e-04 | 65 | 76 | 4 | PS50092 | |
| Domain | hEGF | 1.97e-04 | 28 | 76 | 3 | PF12661 | |
| Domain | IF | 2.11e-04 | 72 | 76 | 4 | PS00226 | |
| Domain | Filament | 2.23e-04 | 73 | 76 | 4 | PF00038 | |
| Domain | EGF_LAM_2 | 2.43e-04 | 30 | 76 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.43e-04 | 30 | 76 | 3 | PS01248 | |
| Domain | IF | 2.60e-04 | 76 | 76 | 4 | IPR001664 | |
| Domain | ConA-like_dom | 2.68e-04 | 219 | 76 | 6 | IPR013320 | |
| Domain | TB | 3.39e-04 | 7 | 76 | 2 | PF00683 | |
| Domain | GPS | 3.54e-04 | 34 | 76 | 3 | SM00303 | |
| Domain | GPS | 3.86e-04 | 35 | 76 | 3 | PF01825 | |
| Domain | EGF_Lam | 3.86e-04 | 35 | 76 | 3 | SM00180 | |
| Domain | GPS | 4.20e-04 | 36 | 76 | 3 | PS50221 | |
| Domain | PPR | 4.50e-04 | 8 | 76 | 2 | PS51375 | |
| Domain | GPS | 4.55e-04 | 37 | 76 | 3 | IPR000203 | |
| Domain | Laminin_EGF | 4.93e-04 | 38 | 76 | 3 | IPR002049 | |
| Domain | - | 5.33e-04 | 39 | 76 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 5.74e-04 | 40 | 76 | 3 | IPR023415 | |
| Domain | PSI | 7.61e-04 | 44 | 76 | 3 | IPR016201 | |
| Domain | Ldl_recept_a | 8.13e-04 | 45 | 76 | 3 | PF00057 | |
| Domain | PSI | 8.67e-04 | 46 | 76 | 3 | SM00423 | |
| Domain | - | 8.67e-04 | 46 | 76 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 8.67e-04 | 46 | 76 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 9.82e-04 | 48 | 76 | 3 | PS01209 | |
| Domain | CUB | 1.04e-03 | 49 | 76 | 3 | PF00431 | |
| Domain | LDLRA_2 | 1.04e-03 | 49 | 76 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.04e-03 | 49 | 76 | 3 | IPR002172 | |
| Domain | LDLa | 1.04e-03 | 49 | 76 | 3 | SM00192 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.11e-03 | 50 | 76 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.11e-03 | 50 | 76 | 3 | PF00002 | |
| Domain | CUB | 1.11e-03 | 50 | 76 | 3 | SM00042 | |
| Domain | - | 1.24e-03 | 52 | 76 | 3 | 2.60.120.290 | |
| Domain | Ldl_recept_b | 1.44e-03 | 14 | 76 | 2 | PF00058 | |
| Domain | LDLRB | 1.44e-03 | 14 | 76 | 2 | PS51120 | |
| Domain | LY | 1.66e-03 | 15 | 76 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.66e-03 | 15 | 76 | 2 | IPR000033 | |
| Domain | GPCR_2_secretin-like | 1.88e-03 | 60 | 76 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 1.88e-03 | 60 | 76 | 3 | IPR017981 | |
| Domain | UDENN | 1.89e-03 | 16 | 76 | 2 | PS50946 | |
| Domain | DDENN | 1.89e-03 | 16 | 76 | 2 | PS50947 | |
| Domain | DENN | 1.89e-03 | 16 | 76 | 2 | SM00799 | |
| Domain | Sulfatase_CS | 1.89e-03 | 16 | 76 | 2 | IPR024607 | |
| Domain | Laminin_N | 1.89e-03 | 16 | 76 | 2 | IPR008211 | |
| Domain | dDENN | 1.89e-03 | 16 | 76 | 2 | SM00801 | |
| Domain | DENN | 1.89e-03 | 16 | 76 | 2 | PF02141 | |
| Domain | LAMININ_NTER | 1.89e-03 | 16 | 76 | 2 | PS51117 | |
| Domain | dDENN_dom | 1.89e-03 | 16 | 76 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.89e-03 | 16 | 76 | 2 | IPR005113 | |
| Domain | Laminin_N | 1.89e-03 | 16 | 76 | 2 | PF00055 | |
| Domain | dDENN | 1.89e-03 | 16 | 76 | 2 | PF03455 | |
| Domain | DENN | 1.89e-03 | 16 | 76 | 2 | PS50211 | |
| Domain | DENN_dom | 1.89e-03 | 16 | 76 | 2 | IPR001194 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NRXN1 COL28A1 ADAMTS16 LAMA3 LRP4 LAMB1 LTBP2 CAPN5 ITGB1 CTSK CTSL CTSV FBN3 | 1.18e-10 | 300 | 56 | 13 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.36e-08 | 140 | 56 | 8 | M587 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES | 3.28e-06 | 8 | 56 | 3 | M27796 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 1.65e-05 | 13 | 56 | 3 | MM14659 | |
| Pathway | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | 1.65e-05 | 13 | 56 | 3 | M593 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.84e-05 | 258 | 56 | 7 | MM14572 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.64e-05 | 59 | 56 | 4 | M27218 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.51e-04 | 68 | 56 | 4 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.98e-04 | 73 | 56 | 4 | MM15906 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.23e-04 | 30 | 56 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.23e-04 | 30 | 56 | 3 | M27216 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.32e-04 | 76 | 56 | 4 | M27219 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.89e-04 | 87 | 56 | 4 | MM15351 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.19e-04 | 37 | 56 | 3 | M27134 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.43e-04 | 90 | 56 | 4 | M631 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 4.54e-04 | 38 | 56 | 3 | MM14611 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.90e-04 | 39 | 56 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 4.90e-04 | 39 | 56 | 3 | MM15165 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.69e-04 | 41 | 56 | 3 | M27778 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.01e-04 | 44 | 56 | 3 | M26969 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 7.72e-04 | 502 | 56 | 8 | MM14537 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 7.99e-04 | 46 | 56 | 3 | M239 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 7.99e-04 | 46 | 56 | 3 | M48243 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 8.33e-04 | 11 | 56 | 2 | M158 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 8.33e-04 | 11 | 56 | 2 | M525 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.08e-03 | 114 | 56 | 4 | MM14571 | |
| Pathway | WP_11P112_COPY_NUMBER_VARIATION_SYNDROME | 1.42e-03 | 56 | 56 | 3 | M48075 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.70e-03 | 129 | 56 | 4 | M39693 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.70e-03 | 129 | 56 | 4 | M27649 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.79e-03 | 16 | 56 | 2 | M9450 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.82e-03 | 61 | 56 | 3 | M27103 | |
| Pubmed | Whn and mHa3 are components of the genetic hierarchy controlling hair follicle differentiation. | 3.68e-10 | 6 | 79 | 4 | 10559501 | |
| Pubmed | Characterization of a 190-kilobase pair domain of human type I hair keratin genes. | 3.08e-09 | 9 | 79 | 4 | 9756910 | |
| Pubmed | 3.08e-09 | 9 | 79 | 4 | 7686952 | ||
| Pubmed | The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. | 5.12e-09 | 10 | 79 | 4 | 10391933 | |
| Pubmed | Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. | 1.13e-08 | 3 | 79 | 3 | 19028686 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17889653 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17404153 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 30931961 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 22126332 | ||
| Pubmed | Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. | 4.50e-08 | 4 | 79 | 3 | 17068745 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 21251246 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 16939398 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 12782676 | ||
| Pubmed | Cathepsin V, but not cathepsins L, B and K, may release angiostatin-like fragments from plasminogen. | 1.12e-07 | 5 | 79 | 3 | 18163891 | |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 33786919 | ||
| Pubmed | 1.55e-07 | 175 | 79 | 7 | 28071719 | ||
| Pubmed | Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P. | 2.24e-07 | 6 | 79 | 3 | 10760593 | |
| Pubmed | 6.27e-07 | 8 | 79 | 3 | 28835281 | ||
| Pubmed | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. | 6.27e-07 | 8 | 79 | 3 | 22916010 | |
| Pubmed | SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. | 9.38e-07 | 9 | 79 | 3 | 17720696 | |
| Pubmed | NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. | 1.34e-06 | 10 | 79 | 3 | 20428172 | |
| Pubmed | 2.04e-06 | 257 | 79 | 7 | 16335952 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SULF2 FSTL3 TENM3 LRP4 LAMB1 ADGRE5 EWSR1 LTBP2 PLXND1 ITGB1 CTSL LDLR NOTCH1 | 2.96e-06 | 1201 | 79 | 13 | 35696571 |
| Pubmed | Sequence and expression of murine type I hair keratins mHa2 and mHa3. | 4.03e-06 | 14 | 79 | 3 | 7514534 | |
| Pubmed | Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. | 5.09e-06 | 2 | 79 | 2 | 16901266 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19801522 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 36735789 | ||
| Pubmed | Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury. | 5.09e-06 | 2 | 79 | 2 | 28332696 | |
| Pubmed | Impaired turnover of autophagolysosomes in cathepsin L deficiency. | 5.09e-06 | 2 | 79 | 2 | 20536383 | |
| Pubmed | Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. | 5.09e-06 | 2 | 79 | 2 | 16636100 | |
| Pubmed | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation. | 5.09e-06 | 2 | 79 | 2 | 31010818 | |
| Pubmed | HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. | 5.09e-06 | 2 | 79 | 2 | 16192265 | |
| Pubmed | Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality. | 5.09e-06 | 2 | 79 | 2 | 28657777 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20837372 | ||
| Pubmed | SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. | 5.09e-06 | 2 | 79 | 2 | 24726914 | |
| Pubmed | A variant of pulmonary alveolar microlithiasis in nackt mice. | 5.09e-06 | 2 | 79 | 2 | 12014504 | |
| Pubmed | Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis. | 5.09e-06 | 2 | 79 | 2 | 12533435 | |
| Pubmed | Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells. | 5.09e-06 | 2 | 79 | 2 | 36206719 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 3689328 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17671649 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20394677 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21972973 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16705169 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 2835398 | ||
| Pubmed | SULFs in human neoplasia: implication as progression and prognosis factors. | 5.09e-06 | 2 | 79 | 2 | 21599997 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16079282 | ||
| Pubmed | Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. | 5.09e-06 | 2 | 79 | 2 | 18957203 | |
| Pubmed | Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. | 5.09e-06 | 2 | 79 | 2 | 9545226 | |
| Pubmed | Cathepsin L gene expression and promoter activation in rodent granulosa cells. | 5.09e-06 | 2 | 79 | 2 | 14563703 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27294358 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20877570 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19900452 | ||
| Pubmed | Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. | 5.09e-06 | 2 | 79 | 2 | 20479257 | |
| Pubmed | Thymocyte expression of cathepsin L is essential for NKT cell development. | 5.09e-06 | 2 | 79 | 2 | 12368909 | |
| Pubmed | Cloning and characterization of a mouse cysteine proteinase. | 5.09e-06 | 2 | 79 | 2 | 3533924 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 1482371 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12163394 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20347002 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15154914 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26448642 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 35131262 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12054558 | ||
| Pubmed | Cathepsin LÂ is involved in proliferation and invasion of breast cancer cells. | 5.09e-06 | 2 | 79 | 2 | 26639231 | |
| Pubmed | An alternate targeting pathway for procathepsin L in mouse fibroblasts. | 5.09e-06 | 2 | 79 | 2 | 11929604 | |
| Pubmed | Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis. | 5.09e-06 | 2 | 79 | 2 | 20023699 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25558848 | ||
| Pubmed | Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels. | 5.09e-06 | 2 | 79 | 2 | 18469859 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34489650 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 1689759 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17920055 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24719048 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12368295 | ||
| Pubmed | Cathepsin L plays an active role in involution of the mouse mammary gland. | 5.09e-06 | 2 | 79 | 2 | 12815617 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23418199 | ||
| Pubmed | NELL-1 promotes cell adhesion and differentiation via Integrinβ1. | 5.09e-06 | 2 | 79 | 2 | 22807400 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16621972 | ||
| Pubmed | Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis. | 5.09e-06 | 2 | 79 | 2 | 33540247 | |
| Pubmed | The protease cathepsin L regulates Th17 cell differentiation. | 5.09e-06 | 2 | 79 | 2 | 26343333 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20338168 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34324645 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18687675 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 31461325 | ||
| Pubmed | Functional consequences of the subdomain organization of the sulfs. | 5.09e-06 | 2 | 79 | 2 | 19520866 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27586811 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23912553 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28266574 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23950901 | ||
| Pubmed | Cathepsin L Helps to Defend Mice from Infection with Influenza A. | 5.09e-06 | 2 | 79 | 2 | 27716790 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16393949 | ||
| Pubmed | Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization. | 5.09e-06 | 2 | 79 | 2 | 20304958 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 11978977 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 2275556 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 11398968 | ||
| Pubmed | Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis. | 5.09e-06 | 2 | 79 | 2 | 23600672 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12466121 | ||
| Pubmed | Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection. | 5.09e-06 | 2 | 79 | 2 | 23480519 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 10516062 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19096818 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 11023992 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 3755373 | ||
| Interaction | FBXO2 interactions | SULF2 TRIM25 TENM3 SULF1 LAMA3 LAMB1 PLXND1 SLC12A7 ITGB1 CTSV NOTCH1 | 2.93e-07 | 411 | 74 | 11 | int:FBXO2 |
| Interaction | IGFL3 interactions | 3.29e-07 | 75 | 74 | 6 | int:IGFL3 | |
| Interaction | TAFA2 interactions | 7.92e-07 | 47 | 74 | 5 | int:TAFA2 | |
| Interaction | LLCFC1 interactions | 5.49e-06 | 121 | 74 | 6 | int:LLCFC1 | |
| Interaction | IGSF5 interactions | 1.68e-05 | 14 | 74 | 3 | int:IGSF5 | |
| Interaction | DEFA1 interactions | 3.34e-05 | 100 | 74 | 5 | int:DEFA1 | |
| Interaction | C1orf54 interactions | 3.44e-05 | 167 | 74 | 6 | int:C1orf54 | |
| Interaction | CTSK interactions | 4.41e-05 | 19 | 74 | 3 | int:CTSK | |
| Interaction | ATN1 interactions | 6.47e-05 | 187 | 74 | 6 | int:ATN1 | |
| Interaction | LAMA5 interactions | 7.08e-05 | 117 | 74 | 5 | int:LAMA5 | |
| Interaction | KRT85 interactions | 7.46e-05 | 61 | 74 | 4 | int:KRT85 | |
| Interaction | KRT80 interactions | 9.01e-05 | 64 | 74 | 4 | int:KRT80 | |
| Interaction | NTN5 interactions | 9.10e-05 | 24 | 74 | 3 | int:NTN5 | |
| Interaction | DENND5B interactions | 9.10e-05 | 24 | 74 | 3 | int:DENND5B | |
| Interaction | LTBP4 interactions | 1.08e-04 | 67 | 74 | 4 | int:LTBP4 | |
| Interaction | FBLN1 interactions | 1.12e-04 | 129 | 74 | 5 | int:FBLN1 | |
| Interaction | ST14 interactions | 1.13e-04 | 207 | 74 | 6 | int:ST14 | |
| Interaction | CELSR1 interactions | 1.14e-04 | 68 | 74 | 4 | int:CELSR1 | |
| Interaction | P2RX7 interactions | 1.16e-04 | 26 | 74 | 3 | int:P2RX7 | |
| Interaction | CFAP90 interactions | 1.32e-04 | 5 | 74 | 2 | int:CFAP90 | |
| Interaction | OS9 interactions | 1.54e-04 | 219 | 74 | 6 | int:OS9 | |
| Cytoband | 19p13 | 1.39e-05 | 27 | 79 | 3 | 19p13 | |
| Cytoband | 5p15 | 6.11e-05 | 7 | 79 | 2 | 5p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.37e-03 | 473 | 79 | 5 | chr17q21 | |
| Cytoband | 17q12-q21 | 1.40e-03 | 32 | 79 | 2 | 17q12-q21 | |
| GeneFamily | Keratins, type I | 1.60e-06 | 28 | 56 | 4 | 608 | |
| GeneFamily | Cathepsins | 1.25e-05 | 15 | 56 | 3 | 470 | |
| GeneFamily | Laminin subunits | 6.10e-04 | 12 | 56 | 2 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 7.19e-04 | 13 | 56 | 2 | 634 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.33e-03 | 394 | 56 | 6 | 471 | |
| GeneFamily | Sulfatases | 1.40e-03 | 18 | 56 | 2 | 410 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.56e-03 | 19 | 56 | 2 | 50 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.91e-03 | 21 | 56 | 2 | 89 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.70e-03 | 25 | 56 | 2 | 504 | |
| Coexpression | NABA_MATRISOME | NELL1 EYS SULF2 OIT3 FSTL3 SULF1 COL28A1 SLIT3 ADAMTS16 LAMA3 LAMB1 LTBP2 ADAMTS13 PLXND1 CLEC10A ELSPBP1 SSPOP CTSK CTSL CTSV FBN3 | 1.14e-12 | 1026 | 77 | 21 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.08e-10 | 196 | 77 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | NELL1 EYS OIT3 COL28A1 SLIT3 LAMA3 LAMB1 LTBP2 ELSPBP1 SSPOP FBN3 | 5.03e-10 | 275 | 77 | 11 | M5884 |
| Coexpression | NABA_MATRISOME | NELL1 SULF2 OIT3 FSTL3 SULF1 COL28A1 SLIT3 ADAMTS16 LAMA3 LAMB1 LTBP2 ADAMTS13 PLXND1 CLEC10A SSPOP CTSK CTSL CTSV | 5.59e-10 | 1008 | 77 | 18 | MM17056 |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 3.28e-07 | 93 | 77 | 6 | M18750 | |
| Coexpression | NABA_CORE_MATRISOME | 1.30e-06 | 270 | 77 | 8 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.53e-06 | 191 | 77 | 7 | MM17059 | |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 2.46e-06 | 73 | 77 | 5 | M1561 | |
| Coexpression | NABA_ECM_REGULATORS | 6.53e-06 | 238 | 77 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 7.28e-06 | 242 | 77 | 7 | MM17062 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.26e-05 | 174 | 77 | 6 | M45676 | |
| Coexpression | BURTON_ADIPOGENESIS_7 | 1.67e-05 | 52 | 77 | 4 | MM685 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 3.81e-05 | 313 | 77 | 7 | M40228 | |
| Coexpression | NADLER_OBESITY_UP | 4.59e-05 | 67 | 77 | 4 | MM1007 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SULF2 FSTL3 SULF1 ADAMTS16 ADAMTS13 PLXND1 CLEC10A CTSK CTSL CTSV | 5.90e-05 | 738 | 77 | 10 | MM17058 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | OIT3 CLCN5 CSF3R SULF1 DENND4B CD53 ADGRE5 LTBP2 CLEC10A CTSK PLAC8 GPR179 LRRC52 | 6.20e-05 | 1242 | 77 | 13 | M1920 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SULF2 FSTL3 SULF1 ADAMTS16 ADAMTS13 PLXND1 CLEC10A CTSK CTSL CTSV | 6.82e-05 | 751 | 77 | 10 | M5885 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP | 7.40e-05 | 147 | 77 | 5 | M6765 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | NRXN1 SULF1 COL28A1 SLIT3 SERTAD4 LTBP2 CTSK LDLR PCDH18 GFRA1 | 8.12e-05 | 767 | 77 | 10 | M39209 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 8.19e-05 | 479 | 77 | 8 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 8.67e-05 | 483 | 77 | 8 | MM1082 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 9.99e-05 | 365 | 77 | 7 | M39018 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | OIT3 CLCN5 CSF3R SULF1 DENND4B CD53 ADGRE5 LTBP2 CLEC10A CTSK PLAC8 GPR179 LRRC52 | 1.11e-04 | 1316 | 77 | 13 | MM1052 |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.25e-04 | 33 | 77 | 3 | M9167 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 1.72e-04 | 94 | 77 | 4 | M18108 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 1.87e-04 | 283 | 77 | 6 | M39117 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_UP | 2.18e-04 | 100 | 77 | 4 | M11028 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 2.35e-04 | 102 | 77 | 4 | M14455 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 2.66e-04 | 302 | 77 | 6 | MM16604 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN | 3.04e-04 | 199 | 77 | 5 | M3718 | |
| Coexpression | GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN | 3.04e-04 | 199 | 77 | 5 | M4094 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | 3.04e-04 | 199 | 77 | 5 | M5729 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B1_BCELL_DN | 3.11e-04 | 200 | 77 | 5 | M6468 | |
| Coexpression | GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP | 3.11e-04 | 200 | 77 | 5 | M8097 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN | 3.11e-04 | 200 | 77 | 5 | M7644 | |
| Coexpression | GSE13306_TREG_RA_VS_TCONV_RA_DN | 3.11e-04 | 200 | 77 | 5 | M3227 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 3.11e-04 | 200 | 77 | 5 | M6484 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN | 3.11e-04 | 200 | 77 | 5 | M8531 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_4H_BMDC_DN | 3.11e-04 | 200 | 77 | 5 | M3942 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP | 3.11e-04 | 200 | 77 | 5 | M9235 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_16H_BMDC_UP | 3.11e-04 | 200 | 77 | 5 | M3950 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN | 3.11e-04 | 200 | 77 | 5 | M3975 | |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 3.11e-04 | 200 | 77 | 5 | M3038 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN | 3.11e-04 | 200 | 77 | 5 | M6956 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 3.41e-04 | 204 | 77 | 5 | MM966 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 3.73e-04 | 208 | 77 | 5 | M39139 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 3.97e-04 | 117 | 77 | 4 | M45663 | |
| Coexpression | BURTON_ADIPOGENESIS_7 | 4.07e-04 | 49 | 77 | 3 | M1616 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 5.22e-04 | 630 | 77 | 8 | MM1038 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 5.25e-04 | 126 | 77 | 4 | M39132 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | TENM3 SULF1 ATRNL1 SLIT3 LAMB1 ADGRF5 CSMD1 CTSK CTSL PCDH18 | 3.20e-06 | 445 | 74 | 10 | GSM777043_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | NELL1 HAVCR1 CSF3R NRXN1 SULF1 ATRNL1 SLIT3 ADAMTS16 SLC34A2 MINAR1 PLCL1 GFRA1 FBN3 | 3.24e-05 | 986 | 74 | 13 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_200 | 4.35e-05 | 56 | 74 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | NELL1 SULF2 NRXN1 TENM3 SULF1 ATRNL1 SLIT3 DISP2 CSMD3 PCDH18 GFRA1 | 4.49e-05 | 734 | 74 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | NELL1 SULF2 TENM3 SULF1 ATRNL1 ADAMTS16 ADGRE5 KCNT1 PCDH18 DENND4C PLAC8 | 4.83e-05 | 740 | 74 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | HAVCR1 FSTL3 SLIT3 ADAMTS16 LAMA3 LAMB1 LTBP2 ITGB1 PLP2 LDLR PLAC8 | 6.22e-05 | 761 | 74 | 11 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.65e-05 | 508 | 74 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K1 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 7.59e-05 | 125 | 74 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 9.09e-05 | 411 | 74 | 8 | GSM538239_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | NELL1 SULF2 TENM3 SULF1 ATRNL1 ADAMTS16 LAMB1 KCNT1 PCDH18 DENND4C PLAC8 | 9.39e-05 | 797 | 74 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.83e-04 | 455 | 74 | 8 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.15e-04 | 466 | 74 | 8 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 2.49e-04 | 161 | 74 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#2 | 2.65e-04 | 255 | 74 | 6 | Arv_EB-LF_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.83e-04 | 616 | 74 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 3.09e-04 | 371 | 74 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 3.31e-04 | 497 | 74 | 8 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.75e-04 | 383 | 74 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| CoexpressionAtlas | lung | 4.37e-04 | 182 | 74 | 5 | lung | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | 5.01e-04 | 529 | 74 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.08e-04 | 530 | 74 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 5.19e-04 | 189 | 74 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.62e-04 | 410 | 74 | 7 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | NELL1 SULF2 CSF3R NRXN1 TENM3 SULF1 ATRNL1 SLIT3 SERTAD4 ADGRB2 CLEC10A PCDH18 | 5.77e-04 | 1148 | 74 | 12 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_200 | 5.90e-04 | 47 | 74 | 3 | gudmap_kidney_adult_RenCorpuscGlomer_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | 5.94e-04 | 831 | 74 | 10 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 6.04e-04 | 415 | 74 | 7 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.14e-04 | 111 | 74 | 4 | gudmap_developingKidney_e11.5_ureteric bud_1000_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | NELL1 HAVCR1 SOHLH2 CSF3R SULF1 ATRNL1 SLIT3 ADAMTS16 CSMD1 GFRA1 FBN3 | 6.16e-04 | 992 | 74 | 11 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | NELL1 HAVCR1 SULF1 ATRNL1 SLIT3 ADAMTS16 SLC34A2 PLCL1 CSMD1 GFRA1 FBN3 | 6.26e-04 | 994 | 74 | 11 | PCBC_EB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.39e-04 | 419 | 74 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.48e-04 | 420 | 74 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | SLC6A4 OIT3 CD53 LRP4 LAMB1 ADGRF5 ADGRE5 PLCL1 PLXND1 NOTCH1 | 6.82e-04 | 846 | 74 | 10 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 6.88e-04 | 847 | 74 | 10 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.76e-04 | 433 | 74 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K1 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 7.76e-04 | 433 | 74 | 7 | GSM605856_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 8.18e-04 | 437 | 74 | 7 | GSM777046_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 8.40e-04 | 53 | 74 | 3 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.53e-04 | 211 | 74 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | NELL1 ATRNL1 VEPH1 ADGRB2 ADGRE5 LTBP2 PLCL1 CLEC10A CTSK GPR179 | 9.06e-04 | 878 | 74 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 9.34e-04 | 447 | 74 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Endothelial_2500_K0 | 9.87e-04 | 126 | 74 | 4 | gudmap_RNAseq_e15.5_Endothelial_2500_K0 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.09e-03 | 459 | 74 | 7 | GSM777037_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 1.13e-03 | 904 | 74 | 10 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.13e-03 | 462 | 74 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K1 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.14e-03 | 131 | 74 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 1.14e-03 | 463 | 74 | 7 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.14e-03 | 463 | 74 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.78e-11 | 197 | 79 | 9 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-11 | 198 | 79 | 9 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 8.90e-11 | 200 | 79 | 9 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-09 | 186 | 79 | 8 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-09 | 199 | 79 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-09 | 200 | 79 | 8 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-09 | 200 | 79 | 8 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.64e-09 | 200 | 79 | 8 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-08 | 157 | 79 | 7 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-08 | 157 | 79 | 7 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.45e-08 | 181 | 79 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.16e-08 | 192 | 79 | 7 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-08 | 193 | 79 | 7 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.16e-08 | 197 | 79 | 7 | eb07545bef5ad506fbbe3a1f99131f26c1447a31 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-08 | 198 | 79 | 7 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-08 | 199 | 79 | 7 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.83e-08 | 200 | 79 | 7 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-08 | 200 | 79 | 7 | 3e6730c9ed7003a4acf501f699a4965a7a50f946 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.83e-08 | 200 | 79 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.83e-08 | 200 | 79 | 7 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.83e-08 | 200 | 79 | 7 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-07 | 164 | 79 | 6 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-07 | 164 | 79 | 6 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.13e-07 | 166 | 79 | 6 | 3b67064a5149e72f895344d938c64b8ff65247f5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.89e-07 | 170 | 79 | 6 | b5b47fe42617a4c2ebb49c8ed55db3926213a75a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-07 | 173 | 79 | 6 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-07 | 173 | 79 | 6 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.98e-07 | 175 | 79 | 6 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.98e-07 | 175 | 79 | 6 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.50e-07 | 181 | 79 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-07 | 181 | 79 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.06e-07 | 183 | 79 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.06e-07 | 183 | 79 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.03e-06 | 187 | 79 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 189 | 79 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 190 | 79 | 6 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-06 | 191 | 79 | 6 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-06 | 191 | 79 | 6 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 191 | 79 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-06 | 192 | 79 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-06 | 193 | 79 | 6 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.24e-06 | 193 | 79 | 6 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 194 | 79 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-06 | 195 | 79 | 6 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-06 | 195 | 79 | 6 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-06 | 195 | 79 | 6 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-06 | 196 | 79 | 6 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 1.35e-06 | 196 | 79 | 6 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-06 | 196 | 79 | 6 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 196 | 79 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 196 | 79 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.39e-06 | 197 | 79 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-06 | 197 | 79 | 6 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 197 | 79 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-06 | 198 | 79 | 6 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 199 | 79 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 1.48e-06 | 199 | 79 | 6 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 1.48e-06 | 199 | 79 | 6 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 199 | 79 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-06 | 199 | 79 | 6 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 199 | 79 | 6 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 199 | 79 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-06 | 199 | 79 | 6 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-06 | 199 | 79 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 199 | 79 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.48e-06 | 199 | 79 | 6 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 199 | 79 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 199 | 79 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 1.48e-06 | 199 | 79 | 6 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-06 | 199 | 79 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 199 | 79 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-06 | 199 | 79 | 6 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-06 | 199 | 79 | 6 | 137ff58897e6ada8a5a70205f66fe9110795506b | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.48e-06 | 199 | 79 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.52e-06 | 200 | 79 | 6 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-06 | 200 | 79 | 6 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | f78968d4b4d907094b2c44dcf5ac557ae94e4484 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-06 | 200 | 79 | 6 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 1.52e-06 | 200 | 79 | 6 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-06 | 200 | 79 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-06 | 200 | 79 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.59e-06 | 122 | 79 | 5 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 2.81e-06 | 124 | 79 | 5 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 3.41e-06 | 129 | 79 | 5 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.91e-06 | 139 | 79 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 5.09e-06 | 140 | 79 | 5 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.45e-06 | 142 | 79 | 5 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-06 | 145 | 79 | 5 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 147 | 79 | 5 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-06 | 147 | 79 | 5 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.67e-06 | 148 | 79 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-06 | 149 | 79 | 5 | aedbae2dffa1e880e5c6a146b6d5a135e7f54308 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.89e-06 | 149 | 79 | 5 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.89e-06 | 149 | 79 | 5 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-06 | 150 | 79 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 160 | 79 | 5 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 162 | 79 | 5 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| Drug | AC1L1I0J | 4.28e-07 | 19 | 76 | 4 | CID000004371 | |
| Drug | Vistar | 6.23e-06 | 36 | 76 | 4 | CID000040896 | |
| Drug | 12-tungstophosphate | 1.10e-05 | 2 | 76 | 2 | CID006398471 | |
| Drug | 3-Amino-5-Phenylpentane | 1.10e-05 | 2 | 76 | 2 | DB02869 | |
| Drug | 9-(5',5'-difluoro-5'-phosphonopentyl)guanine | 1.68e-05 | 46 | 76 | 4 | CID000448999 | |
| Drug | NSC34533 | 3.19e-05 | 54 | 76 | 4 | CID000003512 | |
| Drug | quinoline-8-carboxamide | 3.29e-05 | 3 | 76 | 2 | CID000150664 | |
| Drug | DOPAC | 3.68e-05 | 112 | 76 | 5 | CID000000547 | |
| Disease | otitis media (biomarker_via_orthology) | 1.18e-05 | 17 | 78 | 3 | DOID:10754 (biomarker_via_orthology) | |
| Disease | Proteinuria | 2.03e-04 | 43 | 78 | 3 | C0033687 | |
| Disease | systemic lupus erythematosus (is_marker_for) | 2.65e-04 | 47 | 78 | 3 | DOID:9074 (is_marker_for) | |
| Disease | Asthma, Occupational | 3.06e-04 | 10 | 78 | 2 | C0264423 | |
| Disease | response to cisplatin, platinum measurement | 3.78e-04 | 53 | 78 | 3 | EFO_0010154, GO_0072718 | |
| Disease | retinal vasculature measurement | 4.40e-04 | 517 | 78 | 7 | EFO_0010554 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 4.48e-04 | 12 | 78 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | 4.71e-04 | 523 | 78 | 7 | EFO_0005193 | |
| Disease | Hallux valgus | 5.46e-04 | 60 | 78 | 3 | HP_0001822 | |
| Disease | schizophrenia (implicated_via_orthology) | 7.87e-04 | 68 | 78 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | joint damage measurement | 7.87e-04 | 68 | 78 | 3 | EFO_0005413 | |
| Disease | Amphetamine-Related Disorders | 1.05e-03 | 75 | 78 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 1.05e-03 | 75 | 78 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 1.05e-03 | 75 | 78 | 3 | C0236804 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.26e-03 | 80 | 78 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:9 measurement | 1.54e-03 | 22 | 78 | 2 | EFO_0010443 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.61e-03 | 189 | 78 | 4 | EFO_0009932 | |
| Disease | QRS duration, response to sulfonylurea | 1.68e-03 | 23 | 78 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | eye color | 1.77e-03 | 90 | 78 | 3 | EFO_0003949 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.83e-03 | 91 | 78 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | congenital heart disease (is_implicated_in) | 1.83e-03 | 24 | 78 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 1.83e-03 | 24 | 78 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | parental longevity | 1.98e-03 | 494 | 78 | 6 | EFO_0007796 | |
| Disease | pallidum volume change measurement, age at assessment | 1.99e-03 | 25 | 78 | 2 | EFO_0008007, EFO_0021494 | |
| Disease | albuminuria | 2.00e-03 | 94 | 78 | 3 | EFO_0004285 | |
| Disease | colorectal health | 2.01e-03 | 201 | 78 | 4 | EFO_0008460 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.15e-03 | 26 | 78 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.32e-03 | 99 | 78 | 3 | EFO_0004639, EFO_0008595 | |
| Disease | myocardial infarction | 2.37e-03 | 350 | 78 | 5 | EFO_0000612 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 2.49e-03 | 28 | 78 | 2 | DOID:7998 (biomarker_via_orthology) | |
| Disease | lumbar disc degeneration | 2.49e-03 | 28 | 78 | 2 | EFO_0004994 | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.53e-03 | 102 | 78 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.60e-03 | 103 | 78 | 3 | EFO_0008595, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NNSSQFTCGVLCRWS | 191 | O60241 | |
| KNQGQCGSCWAFSSV | 131 | P43235 | |
| NPGCGNQNFAWRTEC | 526 | Q01844 | |
| SSCCAGWLEFSGQQL | 266 | Q8NCV1 | |
| FLQCCGINGTSDWTS | 141 | P19397 | |
| SLPAASNPSLANNCW | 51 | Q9N2J8 | |
| GNSLWVQSSGACAFC | 136 | A4D250 | |
| NQWSGNKPSCVFSCF | 571 | Q96PZ7 | |
| ICQQDHNWSGQLPSC | 2856 | Q7Z407 | |
| NQKQCGSCWAFSATG | 131 | O60911 | |
| QDSRGCARWCPQNSS | 21 | P48960 | |
| NVSWNHNGSLFCSAC | 181 | Q9BR76 | |
| GQVGNCWFVAACSSL | 76 | O15484 | |
| NSLLCDNGWCQNSPG | 731 | Q75N90 | |
| DNGWCQNSPGSYSCS | 736 | Q75N90 | |
| CSCPQGFTQHSQWAQ | 2551 | Q75N90 | |
| FNASWCSIGASRNCQ | 186 | Q8IVL8 | |
| ANQCCPSWSLGNYLA | 331 | A7MBM2 | |
| GCWGPSHFQQSCLQA | 26 | Q76LX8 | |
| SSRQACNSQSCPPAW | 976 | Q8TE57 | |
| AGPNCGWCTNSTFLQ | 41 | P05556 | |
| WAASTHFQNPTTNCG | 1056 | Q9HCL0 | |
| YTGPNCQNLVHWCDS | 1051 | P46531 | |
| WQNNYTQCAPCASLS | 1071 | Q8NEZ4 | |
| RCLPDWAGNTCNQSV | 2921 | Q5T1H1 | |
| PICQACWCSALGSYQ | 531 | Q16787 | |
| NIPANVSNCNWFCEG | 36 | Q15323 | |
| VSNCNWFCEGSFNGS | 41 | Q15323 | |
| WSLAPQGSHGCCSQN | 21 | P59942 | |
| QCASGPGWYSNTHLC | 281 | Q6PRD1 | |
| IACGPAQSFAWSSCS | 766 | O95714 | |
| CWGCPKQNYSFNDSS | 126 | Q5JUK3 | |
| SCLSAQWPCFWCSQQ | 716 | Q9Y4D7 | |
| NLAQFWECCSSSSGD | 586 | Q92628 | |
| QRQACASFNGNCCLW | 101 | Q8WWZ8 | |
| SETAGAWQCFMCNNP | 691 | Q14D04 | |
| NIPANVSNCNWFCEG | 36 | O76009 | |
| VSNCNWFCEGSFNGS | 41 | O76009 | |
| CCPGWSTAAQSQLTA | 206 | A0A1B0GTW7 | |
| NTWQLASGTGCDPCN | 1071 | P07942 | |
| LSGNPWKCNCSFLDF | 181 | Q8N7C0 | |
| SCSNQGVCLQQWDGF | 1091 | Q9ULB1 | |
| TCWNDSACINLAGGF | 606 | Q92832 | |
| RLSAPGCWAACTNFS | 6 | Q04941 | |
| CNQLAASCWAAGFLN | 141 | Q9UGF6 | |
| SCARFWFSGCNGSGN | 1096 | Q2UY09 | |
| SLSVAPWCDCSNSGN | 306 | P56159 | |
| CCASGNIDTAWSNLT | 61 | O95633 | |
| FNSWCSQGADCITPG | 556 | P51795 | |
| WTADDSNLNTACPFC | 1511 | Q5VZ89 | |
| LEWQTATCSPQNCSG | 931 | Q5VV63 | |
| WSFIQCPACQCNGHS | 1006 | Q5VV63 | |
| QAFLSCCLNWGNSLQ | 96 | Q99062 | |
| GQCCPGWTTANSTNH | 171 | Q14767 | |
| WAPDDSNLNTTCPFC | 1176 | O75064 | |
| NSCISQGSFLGSLWC | 86 | Q96BH3 | |
| NNSATSALWGLFCNG | 331 | Q9Y666 | |
| SPEAWCAAGNCFSLQ | 566 | P30260 | |
| ENNPDWCCSDASGSN | 676 | Q9UPX6 | |
| ASQAGSNYPRCWNCG | 31 | Q8IWL3 | |
| QSCFVQACPVAGAWA | 2546 | A2VEC9 | |
| AQWNCTACTFLNHPA | 666 | Q9NYJ8 | |
| ACNIPANVSNCNWFC | 76 | O76011 | |
| ANVSNCNWFCEGSFN | 81 | O76011 | |
| CWNRGSCSLFTCQNG | 46 | Q96D42 | |
| AGAAAQAAWLSSCCN | 6 | A0A2R8YCJ5 | |
| QAAWLSSCCNQSASP | 11 | A0A2R8YCJ5 | |
| QNNWCFPACSFNGTS | 146 | Q9NUC0 | |
| PVSLNCCSQGNVNWS | 386 | Q8IZF2 | |
| CCHFTNAANNSVWSP | 641 | Q8IZF2 | |
| NQGQCGSCWAFSATG | 131 | P07711 | |
| NNNASTEGTCCPVNW | 171 | Q8IUN9 | |
| NCSISCFWETQPLGC | 6 | Q8NA57 | |
| TPSHTQAQCCLNFGW | 201 | A8MTZ7 | |
| NCTSPSLCWTDGIQN | 321 | O95436 | |
| LSNPFNCNCHLAWLG | 661 | O75094 | |
| CPECGQTFRWASNLQ | 206 | Q96C28 | |
| SSNLNPQDFWNCGCQ | 651 | Q15111 | |
| CGECWKSFNQSSNLL | 796 | P17040 | |
| NFCGSCLNETWAVQG | 31 | Q14258 | |
| LCNSNGRCTLDQNGW | 746 | Q9P273 | |
| WIQRPQNCNTGSSGC | 186 | Q5T750 | |
| PQNSNWQTGMCDCFS | 21 | Q9NZF1 | |
| RGLQFLTNTCWNGCS | 306 | Q9NX45 | |
| PWTSCKNSWNTGNCT | 196 | P31645 | |
| TAPFWNLGSFCACTS | 756 | Q8IWU6 | |
| WTLGPFCACTSANNN | 741 | Q8IWU5 | |
| ASFQCNSSTCIPQLW | 151 | P01130 | |
| NIPANVSNCNWFCEG | 36 | Q14525 | |
| VSNCNWFCEGSFNGS | 41 | Q14525 | |
| NTGSPQCALDQFLCW | 306 | O75096 |